BioDrugs

Acknowledgment
pp. 325-326(2)
Author: Adis International Limited,

The Therapeutic Potential of Intrabodies in Neurologic Disorders: Focus on Huntington and Parkinson Diseases
pp. 327-333(7)
Authors: Messer, Anne; McLear, Julie

Evolving Strategies for the Prevention of Influenza Infection: Potential for Multistrain Targeting
pp. 335-340(6)
Authors: Livingston, Brian D.; Higgins, Debbie; Gary Van Nest,

Progress in the Development of Immune-Based Therapies for Type 1 Diabetes Mellitus
pp. 341-350(10)
Authors: Matthias von Herrath,; Rottembourg, Diane; Bresson, Damien

BioMEMS Sensor Systems for Bacterial Infection Detection: Progress and Potential
pp. 351-356(6)
Author: Ivanov, Dentcho

Effects of Site-Specific Polyethylene Glycol Modification of Recombinant Human Granulocyte Colony-Stimulating Factor on its Biologic Activities
pp. 357-362(6)
Authors: Hao, Yong; Chen, Junhui; Wang, Xinchang; Zhu, Haowen; Rong, Zhigang

An Experimental Model for the Study of Lymphedema and its Response to Therapeutic Lymphangiogenesis
pp. 363-370(8)
Authors: Cheung, Lauren; Han, Jennifer; Beilhack, Andreas; Joshi, Smita; Wilburn, Paul; Dua, Aman; An, Andrew; Rockson, Stanley G.

Reduced-Antigen, Combined Diphtheria, Tetanus, and Acellular Pertussis Vaccine (Boostrix™): A Review of its Use as a Single-Dose Booster Immunization
pp. 371-389(19)
Authors: Frampton, James E.; Keating, Gillian M.